Galapagos Price Prediction and Hype Density Breakdown

GLPG -- USA Stock  

USD 161.16  2.76  1.74%

We analyze noise-free headlines and recent hype associated with Galapagos NV which may create opportunities for some arbitrage if properly timed. With Galapagos hype-based prediction module you can estimate the value of Galapagos NV from the prospective of Galapagos response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Galapagos over a specific investment horizon. Please also check Galapagos Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

Galapagos After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

Galapagos Estimiated After-Hype Price Volatility

September 17, 2019
Current Value
After-hype Price
Galapagos is very steady asset. Analysis and calculation of next after-hype price of Galapagos NV is based on 3 months time horizon.

Galapagos Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.40% 2.73% 1.40%  0.02% 8 Events / Month8 Events / MonthIn about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Galapagos Hype Timeline

Galapagos NV is currently traded for161.16. The entity has historical hype elasticity of -1.4 and average elasticity to hype of competition of -0.02. Galapagos NV is projected to decline in value after the next headline with price expected to drop to 159.76. The average volatility of media hype impact on the company stock price is about 77.78%. The price decrease on the next news is expected to be -0.87% where as daily expected return is currently at 0.4%. The volatility of related hype on Galapagos is about 4792.84% with expected price after next announcement by competition of 161.14. About 17.0% of the company shares are owned by institutional investors. The company recorded loss per share of 1.69. Galapagos NV had not issued any dividends in recent years. Given the investment horizon of 30 days, the next projected press release will be in about 8 days.
Please also check Galapagos Basic Forecasting Models to cross-verify your projections.

Galapagos Related Hype Analysis

At Risk
DiaMedica Therapeutics(0.02) 6 per month 0.00 (0.0103)  10.72 (9.82)  64.00 
Dynavax Technologies Corporatio(0.19) 7 per month 2.95  0.08  8.52 (3.96)  19.89 
Denali Therapeutics(0.06) 8 per month 0.00 (0.0315)  3.86 (4.68)  12.45 
Equillium(0.26) 8 per month 0.00 (0.12)  8.31 (6.81)  22.57 
Global Cord Blood Corporation(0.07) 8 per month 0.00 (0.07)  4.03 (5.38)  27.06 
Dova Pharmaceuticals 0.34 9 per month 2.53  0.19  9.07 (5.18)  35.98 
Dicerna Pharmaceuticals(0.19) 7 per month 0.00 (0.0227)  4.47 (4.31)  12.46 
Auris Medical Holding Ltd(0.06) 6 per month 1.88  0.0159  3.09 (3.32)  9.50 
NantKwest 0.02 6 per month 3.09  0.09  6.20 (4.72)  23.87 
DelMar Pharmaceuticals(0.08) 10 per month 0.00 (0.13)  7.89 (14.61)  61.35 
Please also check Galapagos Basic Forecasting Models to cross-verify your projections. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.